Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

Cited In for PubMed (Select 11196172)

1.

CCAAT/enhancer-binding protein β promotes receptor activator of nuclear factor-kappa-B ligand (RANKL) expression and osteoclast formation in the synovium in rheumatoid arthritis.

Tsushima H, Okazaki K, Ishihara K, Ushijima T, Iwamoto Y.

Arthritis Res Ther. 2015 Feb 17;17:31. doi: 10.1186/s13075-015-0532-6.

2.

C/EBP transcription factors in human squamous cell carcinoma: selective changes in expression of isoforms correlate with the neoplastic state.

Anand S, Ebner J, Warren CB, Raam MS, Piliang M, Billings SD, Maytin EV.

PLoS One. 2014 Nov 17;9(11):e112073. doi: 10.1371/journal.pone.0112073. eCollection 2014.

3.

C/EBPβ expression is an independent predictor of overall survival in breast cancer patients by MHCII/CD4-dependent mechanism of metastasis formation.

Kurzejamska E, Johansson J, Jirström K, Prakash V, Ananthaseshan S, Boon L, Fuxe J, Religa P.

Oncogenesis. 2014 Nov 3;3:e125. doi: 10.1038/oncsis.2014.38.

4.

TGR5 reduces macrophage migration through mTOR-induced C/EBPβ differential translation.

Perino A, Pols TW, Nomura M, Stein S, Pellicciari R, Schoonjans K.

J Clin Invest. 2014 Dec;124(12):5424-36. doi: 10.1172/JCI76289. Epub 2014 Nov 3.

5.

The induction of C/EBPβ contributes to vitamin D inhibition of ADAM17 expression and parathyroid hyperplasia in kidney disease.

Arcidiacono MV, Yang J, Fernandez E, Dusso A.

Nephrol Dial Transplant. 2015 Mar;30(3):423-33. doi: 10.1093/ndt/gfu311. Epub 2014 Oct 7.

PMID:
25294851
6.

The CCAAT/enhancer-binding protein beta-2 isoform (CEBPβ-2) upregulates galectin-7 expression in human breast cancer cells.

Campion CG, Labrie M, Grosset AA, St-Pierre Y.

PLoS One. 2014 May 2;9(5):e95087. doi: 10.1371/journal.pone.0095087. eCollection 2014.

7.

An isoform of C/EBPβ, LIP, regulates expression of the chemokine receptor CXCR4 and modulates breast cancer cell migration.

Park BH, Kook S, Lee S, Jeong JH, Brufsky A, Lee BC.

J Biol Chem. 2013 Oct 4;288(40):28656-67. doi: 10.1074/jbc.M113.509505. Epub 2013 Aug 21.

8.

MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer.

Johansson J, Berg T, Kurzejamska E, Pang MF, Tabor V, Jansson M, Roswall P, Pietras K, Sund M, Religa P, Fuxe J.

Oncogene. 2013 Dec 12;32(50):5614-24. doi: 10.1038/onc.2013.322. Epub 2013 Aug 19.

9.

Interaction and cooperation of the CCAAT-box enhancer-binding protein β (C/EBPβ) with the homeodomain-interacting protein kinase 2 (Hipk2).

Steinmann S, Coulibaly A, Ohnheiser J, Jakobs A, Klempnauer KH.

J Biol Chem. 2013 Aug 2;288(31):22257-69. doi: 10.1074/jbc.M113.487769. Epub 2013 Jun 19.

10.

CCAAT/enhancer binding protein β (C/EBPβ) isoforms as transcriptional regulators of the pro-invasive CDH3/P-cadherin gene in human breast cancer cells.

Albergaria A, Resende C, Nobre AR, Ribeiro AS, Sousa B, Machado JC, Seruca R, Paredes J, Schmitt F.

PLoS One. 2013;8(2):e55749. doi: 10.1371/journal.pone.0055749. Epub 2013 Feb 6.

11.

Oncogenic KRAS impairs EGFR antibodies' efficiency by C/EBPβ-dependent suppression of EGFR expression.

Derer S, Berger S, Schlaeth M, Schneider-Merck T, Klausz K, Lohse S, Overdijk MB, Dechant M, Kellner C, Nagelmeier I, Scheel AH, Lammerts van Bueren JJ, van de Winkel JG, Parren PW, Peipp M, Valerius T.

Neoplasia. 2012 Mar;14(3):190-205.

12.

Differentiation-dependent changes in levels of C/EBPβ repressors and activators regulate human papillomavirus type 31 late gene expression.

Gunasekharan V, Haché G, Laimins L.

J Virol. 2012 May;86(9):5393-8. doi: 10.1128/JVI.07239-11. Epub 2012 Feb 29.

13.

LIP expression is regulated by IGF-1R signaling and participates in suppression of anoikis.

Li H, Baldwin BR, Zahnow CA.

Mol Cancer. 2011 Aug 19;10:100. doi: 10.1186/1476-4598-10-100.

14.

CCAAT/enhancer-binding protein beta inhibits proliferation in monocytic cells by affecting the retinoblastoma protein/E2F/cyclin E pathway but is not directly required for macrophage morphology.

Gutsch R, Kandemir JD, Pietsch D, Cappello C, Meyer J, Simanowski K, Huber R, Brand K.

J Biol Chem. 2011 Jul 1;286(26):22716-29. doi: 10.1074/jbc.M110.152538. Epub 2011 May 10.

15.

Upstream open reading frames: molecular switches in (patho)physiology.

Wethmar K, Smink JJ, Leutz A.

Bioessays. 2010 Oct;32(10):885-93. doi: 10.1002/bies.201000037. Epub 2010 Aug 19. Review.

16.

The C/EBPbeta isoform, liver-inhibitory protein (LIP), induces autophagy in breast cancer cell lines.

Abreu MM, Sealy L.

Exp Cell Res. 2010 Nov 15;316(19):3227-38. doi: 10.1016/j.yexcr.2010.07.021. Epub 2010 Aug 7.

17.

Molecular symbiosis of CHOP and C/EBP beta isoform LIP contributes to endoplasmic reticulum stress-induced apoptosis.

Chiribau CB, Gaccioli F, Huang CC, Yuan CL, Hatzoglou M.

Mol Cell Biol. 2010 Jul;30(14):3722-31. doi: 10.1128/MCB.01507-09. Epub 2010 May 17.

18.

CCAAT/enhancer-binding protein beta: its role in breast cancer and associations with receptor tyrosine kinases.

Zahnow CA.

Expert Rev Mol Med. 2009 Apr 8;11:e12. doi: 10.1017/S1462399409001033. Review.

19.

Ha-Ras transformation of MCF10A cells leads to repression of Singleminded-2s through NOTCH and C/EBPbeta.

Gustafson TL, Wellberg E, Laffin B, Schilling L, Metz RP, Zahnow CA, Porter WW.

Oncogene. 2009 Mar 26;28(12):1561-8. doi: 10.1038/onc.2008.497. Epub 2009 Jan 26.

20.

Homology with vesicle fusion mediator syntaxin-1a predicts determinants of epimorphin/syntaxin-2 function in mammary epithelial morphogenesis.

Chen CS, Nelson CM, Khauv D, Bennett S, Radisky ES, Hirai Y, Bissell MJ, Radisky DC.

J Biol Chem. 2009 Mar 13;284(11):6877-84. doi: 10.1074/jbc.M805908200. Epub 2009 Jan 7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk